학술논문
Comparative efficacy of tyrosine kinase inhibitor treatments in the third-line setting, for chronic-phase chronic myelogenous leukemia after failure of second-generation tyrosine kinase inhibitors
Document Type
Article
Author
Source
In Leukemia Research January 2015 39(1):58-64
Subject
Language
ISSN
0145-2126